Showing results (641-650 of 1,188) with videos related to

Sort By:
Pageof 119
Elife|July 24, 2013
MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancyStefan Heinrichs, Lillian F Conover, Carlos E Bueso-Ramos, et al.
Journal of Clinical Medicine|November 8, 2018
Pregnancy in Chronic Kidney Disease: Need for Higher Awareness. A Pragmatic Review Focused on What Could Be Improved in the Different CKD Stages and PhasesGiorgina B Piccoli, Elena Zakharova, Rossella Attini, et al.
Journal of Nephrology|July 18, 2020
Correction to: Kidney health for everyone everywhere: from prevention to detection and equitable access to carePhilip Kam-Tao Li, Guillermo Garcia-Garcia, Siu-Fai Lui, et al.
Indian Journal of Nephrology|April 10, 2020
Kidney Health for Everyone Everywhere - From Prevention to Detection and Equitable Access to CarePhilip Kam-Tao Li, Guillermo Garcia-Garcia, Siu-Fai Lui, et al.
Nephron|March 12, 2020
Kidney Health for Everyone Everywhere - From Prevention to Detection and Equitable Access to CarePhilip Kam-Tao Li, Guillermo Garcia-Garcia, Siu-Fai Lui, et al.
Pediatric Nephrology (Berlin, Germany)|June 27, 2020
Kidney health for everyone everywhere-from prevention to detection and equitable access to carePhilip Kam-Tao Li, Guillermo Garcia-Garcia, Siu-Fai Lui, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2003
Randomized phase I/II study of troxacitabine combined with cytarabine, idarubicin, or topotecan in patients with refractory myeloid leukemiasFrancis J Giles, Stefan Faderl, Deborah A Thomas, et al.
Blood|June 7, 2003
Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemiaHagop Kantarjian, Varsha Gandhi, Jorge Cortes, et al.
Cancer|October 21, 2016
Chronic myeloid leukemia among patients with a history of prior malignancies: A tale of dual survivorshipPaul B Koller, Hagop M Kantarjian, Graciela M Nogueras-Gonzalez, et al.
Cancer|March 27, 2015
Final results of a phase 2 trial of clofarabine and low-dose cytarabine alternating with decitabine in older patients with newly diagnosed acute myeloid leukemiaTapan M Kadia, Stefan Faderl, Farhad Ravandi, et al.
Pageof 119